Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

American Academy of Neurology and American Epilepsy Society guidelines for treating of epilepsy

27.04.2004


Treatment guidelines for epilepsy evaluate antiepileptic drugs



The number of drugs available to treat epilepsy have more than doubled in the last decade. The American Academy of Neurology and the American Epilepsy Society have assembled the top experts in the field to evaluate the available data of more than 1,400 research articles in order to create a guideline for the treatment of epilepsy with these new antiepileptic drugs (AEDs).

"These guidelines are designed to provide evidence-based assessments on the use of the new anti-epileptic drugs to clinicians," said Jacqueline French, M.D., professor of neurology at the University of Pennsylvania School of Medicine in Philadelphia and one of the authors of the guidelines.


"The guidelines offer a rigorous, comprehensive and unbiased analysis of the available data on the safety, efficacy and mode of use of these AEDs that the clinician can use in making treatment decisions," said Andres Kanner, M.D., professor of neurological sciences at Rush University Medical Center in Chicago and another author of the guidelines. "This thorough review of the current research on epilepsy can also have a major impact on deciding what our priorities for future research should be," he said.

Dr. French and Dr. Kanner spoke today at an American Medical Association media briefing in partnership with the American Academy of Neurology (AAN) and the American Epilepsy Society at the AAN’s annual meeting in San Francisco.

Because of their previous experience with the older anti-epileptic drugs, doctors are comfortable using them. They need guidance in how and when to use the newer drugs. "There has been an explosion in the field of epilepsy research in the last decade," said Dr. French. "Eight new drugs have been added to the five previously approved drugs commonly used for the treatment of epilepsy. While the older drugs are all effective in preventing seizures, there are some concerns about side effects over the long term."

"Epilepsy often strikes when people are young and patients will be on medication for decades," said Dr. French. "The older drugs are all known to have significant impact on liver metabolism which can affect other drugs a patient takes as well as the body’s own hormone metabolism. Other possible side effects include osteoporosis, sleepiness and confusion. These new drugs may offer a significantly better day-to-day quality of life for the patient who must take them for years."

"Usually when we see a whole new set of drugs approved for treating a condition, they are similar to one another," said Dr. French. "This is a different situation entirely. Each of these new anti-epileptic drugs has an absolutely unique mode of action, unique side effect profile and an unique set of drug interactions. There is great deal of information for the practicing physician to sift through to use these drugs safely and effectively."

There are actually two sets of guidelines, one to treat newly diagnosed epilepsy and one to treat epilepsy that has already proved difficult to manage with the older drugs. "The FDA drug approval process, which requires placebo (or near-placebo) -controlled trials, makes it very difficult to gather some of the kinds of information we need," said Dr. French. "With a life-threatening illness, it is not possible to take people off all medications. We have to use other evidence of effectiveness, as well as European trials where new drugs are compared to older medications, to do our analysis."

"The European equivalent of the FDA has years of studies that provide us with a lot of good data on safety and efficacy of these new AEDs," said Dr. Kanner. "With so many new drugs and an absence of head-to-head comparison studies, we have to rely on on this type of evidence-based assessment of all the available information to give the practicing physician a better way to make a treatment choice."

"For patients who may find themselves paying more for the newer drugs, it is important that they can feel comfortable that the safety and efficacy of these new drugs have been analyzed in an objective and rigorous manner and are being used in an appropriate way," said Dr. Kanner. "There is a real concern in the media today that too much of the information reaching doctors about new drugs may come only from the pharmaceutical industry. These guidelines provide the clinician with an assessment that is in no way driven by the marketplace."


To contact Jacqueline French, M.D., contact Karen Kreeger at 215-349-5658 or karen.kreeger@uphs.upenn.edu. To contact Andrew Kanner, M.D., contact John Pontarelli at 312-942-5949 or jpontare@rush.edu. On the day of the briefing, call the AMA’s Science News Department at 312-464-2410, the AAN Press Room at 415-978-3521, or email kstone@aan.com.

Karen Kreeger | EurekAlert!
Further information:
http://www.ama-assn.org/

More articles from Health and Medicine:

nachricht Using fragment-based approaches to discover new antibiotics
21.06.2018 | SLAS (Society for Laboratory Automation and Screening)

nachricht Scientists learn more about how gene linked to autism affects brain
19.06.2018 | Cincinnati Children's Hospital Medical Center

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Temperature-controlled fiber-optic light source with liquid core

In a recent publication in the renowned journal Optica, scientists of Leibniz-Institute of Photonic Technology (Leibniz IPHT) in Jena showed that they can accurately control the optical properties of liquid-core fiber lasers and therefore their spectral band width by temperature and pressure tuning.

Already last year, the researchers provided experimental proof of a new dynamic of hybrid solitons– temporally and spectrally stationary light waves resulting...

Im Focus: Overdosing on Calcium

Nano crystals impact stem cell fate during bone formation

Scientists from the University of Freiburg and the University of Basel identified a master regulator for bone regeneration. Prasad Shastri, Professor of...

Im Focus: AchemAsia 2019 will take place in Shanghai

Moving into its fourth decade, AchemAsia is setting out for new horizons: The International Expo and Innovation Forum for Sustainable Chemical Production will take place from 21-23 May 2019 in Shanghai, China. With an updated event profile, the eleventh edition focusses on topics that are especially relevant for the Chinese process industry, putting a strong emphasis on sustainability and innovation.

Founded in 1989 as a spin-off of ACHEMA to cater to the needs of China’s then developing industry, AchemAsia has since grown into a platform where the latest...

Im Focus: First real-time test of Li-Fi utilization for the industrial Internet of Things

The BMBF-funded OWICELLS project was successfully completed with a final presentation at the BMW plant in Munich. The presentation demonstrated a Li-Fi communication with a mobile robot, while the robot carried out usual production processes (welding, moving and testing parts) in a 5x5m² production cell. The robust, optical wireless transmission is based on spatial diversity; in other words, data is sent and received simultaneously by several LEDs and several photodiodes. The system can transmit data at more than 100 Mbit/s and five milliseconds latency.

Modern production technologies in the automobile industry must become more flexible in order to fulfil individual customer requirements.

Im Focus: Sharp images with flexible fibers

An international team of scientists has discovered a new way to transfer image information through multimodal fibers with almost no distortion - even if the fiber is bent. The results of the study, to which scientist from the Leibniz-Institute of Photonic Technology Jena (Leibniz IPHT) contributed, were published on 6thJune in the highly-cited journal Physical Review Letters.

Endoscopes allow doctors to see into a patient’s body like through a keyhole. Typically, the images are transmitted via a bundle of several hundreds of optical...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Munich conference on asteroid detection, tracking and defense

13.06.2018 | Event News

2nd International Baltic Earth Conference in Denmark: “The Baltic Sea region in Transition”

08.06.2018 | Event News

ISEKI_Food 2018: Conference with Holistic View of Food Production

05.06.2018 | Event News

 
Latest News

Graphene assembled film shows higher thermal conductivity than graphite film

22.06.2018 | Materials Sciences

Fast rising bedrock below West Antarctica reveals an extremely fluid Earth mantle

22.06.2018 | Earth Sciences

Zebrafish's near 360 degree UV-vision knocks stripes off Google Street View

22.06.2018 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>